Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02575027 · ClinicalTrials.gov registry record · NA

Palliative 4pi Radiotherapy in Treating Patients With Recurrent Glioblastoma Multiforme

A NA study of Glioblastoma and Recurrent Brain Neoplasm, sponsored by Jonsson Comprehensive Cancer Center.

Completed
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT02575027 is a NA study of Glioblastoma and Recurrent Brain Neoplasm that has completed, run by Jonsson Comprehensive Cancer Center. The registered enrollment target is 10 participants, below the 109-participant average among 199 other Glioblastoma trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02575027, a NA study of Glioblastoma and Recurrent Brain Neoplasm, has completed, sponsored by Jonsson Comprehensive Cancer Center.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

This pilot clinical trial studies the feasibility of palliative 4pi radiotherapy in treating patients with glioblastoma multiforme that has come back after standard chemoradiation. A new radiotherapy delivery planning system, called 4pi radiotherapy, may help improve radiation delivery by improving dose coverage to the treatment target, while reducing the dose to surrounding normal tissues.

Interventions

  • OTHER Questionnaire Administration
  • RADIATION Palliative Radiation Therapy
  • RADIATION Radiation Therapy Treatment Planning and Simulation

Study Locations (1)

California

  • UCLA / Jonsson Comprehensive Cancer Center - Los Angeles

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2014-11-12
Est. Completion 2018-06-20
Phase NA

Sponsor

Jonsson Comprehensive Cancer Center

321 total trials

What the Registry Record Tells You About NCT02575027

The ClinicalTrials.gov registry entry for NCT02575027 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 109-participant average among 199 other Glioblastoma trials with a reported enrollment target (91% lower). The listed sponsor is Jonsson Comprehensive Cancer Center, which has 321 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Glioblastoma appearing as the primary indexed condition, and to 3 interventions - of which Questionnaire Administration is the first listed.

NCT02575027 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT02575027 about?

NCT02575027 is a clinical study titled "Palliative 4pi Radiotherapy in Treating Patients With Recurrent Glioblastoma Multiforme". This pilot clinical trial studies the feasibility of palliative 4pi radiotherapy in treating patients with glioblastoma multiforme that has come back after standard chemoradiation. A new radiotherapy delivery planning system, called 4pi radiotherapy, may help improve radiation delivery by improving ...

What is the current status of trial NCT02575027?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2014-11-12. Estimated completion is 2018-06-20.

What conditions does trial NCT02575027 study?

This clinical trial studies the following conditions: Glioblastoma, Recurrent Brain Neoplasm.

What interventions are being tested in trial NCT02575027?

The interventions under investigation include: Questionnaire Administration (OTHER), Palliative Radiation Therapy (RADIATION), Radiation Therapy Treatment Planning and Simulation (RADIATION).

Who is sponsoring clinical trial NCT02575027?

This trial is sponsored by Jonsson Comprehensive Cancer Center, which has 321 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02575027 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Glioblastoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.